Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INSMED IncINSM · Entity 3174 | Chief Compliance Officer | September 07, 2021 | September 09, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INSMED Inc
Report date September 07, 2021 · Filed September 09, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 35,204 |
Ending reported balance
After 2021-09-07 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2021-09-07 · Exercise / conversion · Acquired 17,349 · Balance 52,553 Row 2 · 2021-09-07 · Sale · Disposed 17,349 · Balance 35,204 F1: This is the weighted average sales price representing the shares sold at prices ranging from $28.11 to $28.37 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $13.91 · Expires 2029-01-03 | Direct | 52,046 |
Reported balance
After 2021-09-07 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-09-07 · Exercise / conversion · Disposed 17,349 · Balance 52,046 F2: The options become exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: This is the weighted average sales price representing the shares sold at prices ranging from $28.11 to $28.37 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F2: The options become exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 07, 2021 Filed Sep 9, 2021 20:10 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option (right to buy) · Derivative | 17,349 | $0.00 Strike: $13.91 | $0.00 |
DisclosureSEC source: 0001140361-21-030808 · form4.xml · derivative · entry 3 SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,046 Underlying: Common Stock · 17,349 shares Expires 2029-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options become exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| September 07, 2021 Filed Sep 9, 2021 20:10 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 17,349 | $28.20 | $489,241.80 |
DisclosureSEC source: 0001140361-21-030808 · form4.xml · nonDerivative · entry 2 SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,204 F1 · price: This is the weighted average sales price representing the shares sold at prices ranging from $28.11 to $28.37 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| September 07, 2021 Filed Sep 9, 2021 20:10 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionCommon Stock | 17,349 | $13.91 | $241,324.59 |
DisclosureSEC source: 0001140361-21-030808 · form4.xml · nonDerivative · entry 1 SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,553 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2021 Filed May 18, 2021 20:48 UTC | INSMED Inc INSM · Entity 3174 | Tax withholdingCommon Stock | 1,655 | $26.23 | $43,410.65 |
DisclosureSEC source: 0001140361-21-017901 · form4.xml · nonDerivative · entry 1 SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,204 F1 · shares: Shares withheld by the Company to satisfy tax withholding requirements on vesting of time-based restricted stock units. Read SEC document |
| May 12, 2021 Filed May 14, 2021 20:54 UTC | INSMED Inc INSM · Entity 3174 | GrantStock Option (right to buy) · Derivative | 34,320 | $0.00 Strike: $26.46 | $0.00 |
DisclosureSEC source: 0001140361-21-017440 · form4.xml · derivative · entry 2 SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,320 Underlying: Common Stock · 34,320 shares Expires 2031-05-12 F3 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| May 12, 2021 Filed May 14, 2021 20:54 UTC | INSMED Inc INSM · Entity 3174 | GrantCommon Stock | 7,086 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-21-017440 · form4.xml · nonDerivative · entry 1 SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,859 F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant. F2 · price: Each Restricted Stock Unit was received as a grant on May 12, 2021, for no consideration. Read SEC document |
| March 11, 2021 Filed Mar 12, 2021 21:20 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option (right to buy) · Derivative | 23,717 | $0.00 Strike: $30.86 | $0.00 |
DisclosureSEC source: 0001140361-21-008324 · form4.xml · derivative · entry 3 SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,550 Underlying: Common Stock · 23,717 shares Expires 2028-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| March 11, 2021 Filed Mar 12, 2021 21:20 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 23,717 | $40.00 | $948,680.00 |
DisclosureSEC source: 0001140361-21-008324 · form4.xml · nonDerivative · entry 2 SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,773 F1 · price: This is the weighted average sales price representing the shares sold at prices ranging from $40.00 to $40.01 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| March 11, 2021 Filed Mar 12, 2021 21:20 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionCommon Stock | 23,717 | $30.86 | $731,906.62 |
DisclosureSEC source: 0001140361-21-008324 · form4.xml · nonDerivative · entry 1 SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,490 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 10, 2021 Filed Mar 11, 2021 21:12 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option (right to buy) · Derivative | 500 | $0.00 Strike: $30.86 | $0.00 |
DisclosureSEC source: 0001140361-21-008183 · form4.xml · derivative · entry 12 SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,267 Underlying: Common Stock · 500 shares Expires 2028-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| March 10, 2021 Filed Mar 11, 2021 21:12 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 500 | $40.00 | $20,000.00 |
DisclosureSEC source: 0001140361-21-008183 · form4.xml · nonDerivative · entry 8 SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,773 F2 · price: This is the weighted average sales price representing the shares sold at prices ranging from $40.00 to $40.01 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| March 10, 2021 Filed Mar 11, 2021 21:12 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionCommon Stock | 500 | $30.86 | $15,430.00 |
DisclosureSEC source: 0001140361-21-008183 · form4.xml · nonDerivative · entry 7 SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,273 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 21:12 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option (right to buy) · Derivative | 14,130 | $0.00 Strike: $23.75 | $0.00 |
DisclosureSEC source: 0001140361-21-008183 · form4.xml · derivative · entry 11 SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,390 Underlying: Common Stock · 14,130 shares Expires 2030-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 21:12 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option (right to buy) · Derivative | 17,349 | $0.00 Strike: $13.91 | $0.00 |
DisclosureSEC source: 0001140361-21-008183 · form4.xml · derivative · entry 10 SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,395 Underlying: Common Stock · 17,349 shares Expires 2029-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 21:12 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option (right to buy) · Derivative | 13,433 | $0.00 Strike: $30.86 | $0.00 |
DisclosureSEC source: 0001140361-21-008183 · form4.xml · derivative · entry 9 SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,767 Underlying: Common Stock · 13,433 shares Expires 2028-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 21:12 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 14,130 | $40.38 | $570,569.40 |
DisclosureSEC source: 0001140361-21-008183 · form4.xml · nonDerivative · entry 6 SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,773 F1 · price: This is the weighted average sales price representing the shares sold at prices ranging from $40.00 to $40.61 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 21:12 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionCommon Stock | 14,130 | $23.75 | $335,587.50 |
DisclosureSEC source: 0001140361-21-008183 · form4.xml · nonDerivative · entry 5 SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,903 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 21:12 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 17,349 | $40.38 | $700,552.62 |
DisclosureSEC source: 0001140361-21-008183 · form4.xml · nonDerivative · entry 4 SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,773 F1 · price: This is the weighted average sales price representing the shares sold at prices ranging from $40.00 to $40.61 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 21:12 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionCommon Stock | 17,349 | $13.91 | $241,324.59 |
DisclosureSEC source: 0001140361-21-008183 · form4.xml · nonDerivative · entry 3 SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,122 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 21:12 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 13,433 | $40.38 | $542,424.54 |
DisclosureSEC source: 0001140361-21-008183 · form4.xml · nonDerivative · entry 2 SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,773 F1 · price: This is the weighted average sales price representing the shares sold at prices ranging from $40.00 to $40.61 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 21:12 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionCommon Stock | 13,433 | $30.86 | $414,542.38 |
DisclosureSEC source: 0001140361-21-008183 · form4.xml · nonDerivative · entry 1 SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,206 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 07, 2021 Filed Jan 8, 2021 21:37 UTC | INSMED Inc INSM · Entity 3174 | GrantStock Option (right to buy) · Derivative | 27,360 | $0.00 Strike: $34.03 | $0.00 |
DisclosureSEC source: 0001104659-21-002505 · tm211774-8_4seq1.xml · derivative · entry 2 SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,360 Underlying: Common Stock · 27,360 shares Expires 2031-01-07 F3 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| January 07, 2021 Filed Jan 8, 2021 21:37 UTC | INSMED Inc INSM · Entity 3174 | GrantCommon Stock | 5,509 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-002505 · tm211774-8_4seq1.xml · nonDerivative · entry 1 SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,773 F1 · shares: Restricted stock units granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant. F2 · price: Each Restricted Stock Unit was received as a grant on January 7, 2021, for no consideration, and represents a contingent right to receive one share of Common Stock. Read SEC document |
| January 03, 2021 Filed Jan 6, 2021 22:13 UTC | INSMED Inc INSM · Entity 3174 | Tax withholdingCommon Stock | 949 | $33.29 | $31,592.21 |
DisclosureSEC source: 0001104659-21-001606 · tm211774d5_4seq1.xml · nonDerivative · entry 1 SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,264 F1 · shares: Shares withheld by the Company to satisfy tax withholding requirements on vesting of time-based restricted stock units. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 21:17 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option (right to buy) · Derivative | 52,046 | $0.00 Strike: $13.91 | $0.00 |
DisclosureSEC source: 0001104659-20-093991 · a4.xml · derivative · entry 4 SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,744 Underlying: Common Stock · 52,046 shares Expires 2029-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 21:17 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 52,046 | $30.29 | $1,576,473.34 |
DisclosureSEC source: 0001104659-20-093991 · a4.xml · nonDerivative · entry 3 SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,213 F2 · price: This is the weighted average sales price representing 52,046 shares sold at prices ranging from $30.12 to $30.49 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 21:17 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionCommon Stock | 52,046 | $13.91 | $723,959.86 |
DisclosureSEC source: 0001104659-20-093991 · a4.xml · nonDerivative · entry 2 SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,259 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2020 Filed Aug 12, 2020 21:17 UTC | INSMED Inc INSM · Entity 3174 | Tax withholdingCommon Stock | 994 | $25.46 | $25,307.24 |
DisclosureSEC source: 0001104659-20-093991 · a4.xml · nonDerivative · entry 1 SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,253 F1 · security: Represents the withholding of shares of common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. This transaction was not reported previously due to a clerical error. Read SEC document |
| January 03, 2020 Filed Jan 7, 2020 23:14 UTC | INSMED Inc INSM · Entity 3174 | GrantStock Option (right to buy) · Derivative | 56,520 | $0.00 Strike: $23.75 | $0.00 |
DisclosureSEC source: 0001127430-20-000027 · edgar.xml · derivative · entry 2 SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,520 Underlying: Common Stock · 56,520 shares Expires 2030-01-03 F4 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| January 03, 2020 Filed Jan 7, 2020 23:14 UTC | INSMED Inc INSM · Entity 3174 | GrantCommon Stock | 10,526 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127430-20-000027 · edgar.xml · nonDerivative · entry 1 SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,207 F1 · shares: Restricted stock units granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant for four years. F2 · price: Each Restricted Stock Unit was received as a grant on January 3, 2020, for no consideration, and represents a contingent right to receive one share of Common Stock. F3 · balance_after: Includes 2,746 shares acquired through the Company's 2018 Employee Stock Purchase Plan. Read SEC document |
| May 15, 2019 Filed May 16, 2019 21:15 UTC | INSMED Inc INSM · Entity 3174 | GrantCommon Stock | 12,935 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127430-19-000072 · edgar.xml · nonDerivative · entry 1 SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,892 F1 · shares: Restricted stock units granted pursuant to the Company's 2017 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant for four years. F2 · price: Each Restricted Stock Unit was received as a grant on May 15, 2019, for no consideration, and represents a contingent right to receive one share of Common Stock. F3 · balance_after: Includes 957 shares acquired through the Company's 2018 Employee Stock Purchase Plan for the six-month period ended December 31, 2018. Read SEC document |
| January 03, 2019 Filed Jan 7, 2019 21:10 UTC | INSMED Inc INSM · Entity 3174 | GrantStock Option · Derivative | 138,790 | $0.00 Strike: $13.91 | $0.00 |
DisclosureSEC source: 0001127430-19-000021 · edgar.xml · derivative · entry 1 SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,790 Underlying: Common Stock · 138,790 shares Expires 2029-01-03 F1 · derivative.exercise_date: Stock options granted under the Company's 2017 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty-five percent (25%) on the first anniversary of the grant date and an additional twelve and one-half percent (12.5%) vest on the six month anniversary of the first anniversary date and each six month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.